AOD-9604 is named explicitly on the WADA 2026 Prohibited List under section S2.2.3 (Growth hormone, its analogs and fragments), prohibited at all times both in-competition and out-of-competition for all athletes under WADA jurisdiction
This includes rheumatoid arthritis, which causes joint pain and swelling
Best candidates for retatrutide Retatrutide makes more sense for researchers who: Need maximum possible weight loss and have not achieved adequate results with dual agonists Have significant liver fat accumulation as a primary concern Have plateaued on tirzepatide or stopped responding Are comfortable with investigational compounds and research-grade sourcing Have higher side effect tolerance Want the most comprehensive metabolic intervention currently available Are experienced with GLP-1 agonist protocols and understand escalation management Have access to medical monitoring during the protocol Retatrutide is not a beginner compound
Complete the form below or contact us at 253-256-9286 today to book a consultation
Mentre Semaglutide agisce principalmente sul recettore GLP-1 e Tirzepatide su GLP-1 e GIP, Retatrutide studiato per la sua azione su tre recettori simultaneamente (GLP-1, GIP e glucagone), offrendo ai ricercatori un modello sperimentale aggiuntivo all'interno dello stesso cluster
GLP-1s curb appetite, while Skinny Shots boost energy and fat burn